During the last session, Abbvie Inc (NYSE:ABBV)’s traded shares were 4.78 million, with the beta value of the company hitting 0.49. At the end of the trading day, the stock’s price was $183.09, reflecting an intraday loss of -1.42% or -$2.63. The 52-week high for the ABBV share is $218.66, that puts it down -19.43 from that peak though still a striking 16.12% gain since the share price plummeted to a 52-week low of $153.58. The company’s market capitalization is $323.41B, and the average trade volume was 8.13 million shares over the past three months.
Abbvie Inc (ABBV) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.90. ABBV has a Sell rating from 0 analyst(s) out of 27 analysts who have looked at this stock. 7 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 20 recommend a Buy rating for it.
Abbvie Inc (NYSE:ABBV) trade information
Abbvie Inc (ABBV) registered a -1.42% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.42% in intraday trading to $183.09, hitting a weekly high. The stock’s 5-day price performance is -0.95%, and it has moved by -4.81% in 30 days. Based on these gigs, the overall price performance for the year is 15.69%.
The consensus price target of analysts on Wall Street is $217.5, which implies an increase of 15.82% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $215 and $220 respectively. As a result, ABBV is trading at a discount of -20.16% off the target high and -17.43% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -14.67%. While earnings are projected to return 20.81% in 2025, the next five years will return 15.20% per annum.
ABBV Dividends
Abbvie Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Abbvie Inc is 6.38, with the dividend yield indicating at 3.48 percent, continuing the trend of increasing dividends in recent years.
Abbvie Inc (NYSE:ABBV)’s Major holders
The next largest institutional holding, with 136.43 million shares, is of BLACKROCK INC.’s that is approximately 7.7124% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $23.4 billion.
Also, the Mutual Funds coming in first place with the largest holdings of Abbvie Inc (ABBV) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund. Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 55.37 shares. This amounts to just over 3.13 percent of the company’s overall shares, with a $10.14 billion market value. The same data shows that the other fund manager holds slightly less at 47.83, or about 2.71% of the stock, which is worth about $8.76 billion.
